You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Adult patients with lymphoma (Non Hodgkin's Lymphoma, Hodgkin's Disease) or Multiple Myeloma who previously failed Stem Cell Collections or Collection attempts.

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lymphoma, Multiple Myeloma, Non-Hodgkin Lymphoma Trial in New York (Isatuximab, Standard Procedures)

Recruiting
  • Lymphoma
  • +3 more
  • New York, New York
    Columbia University
Apr 27, 2022

Non-Hodgkin's Lymphoma, Plasma Cell Myeloma Trial in Philadelphia (procedure, drug, other)

Completed
  • Non-Hodgkin's Lymphoma
  • Plasma Cell Myeloma
  • Hematopoietic Cell Transplantation
  • +2 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Nov 16, 2022

Multiple Myeloma, CLL, Chronic Lymphocytic Leukemia Trial in Los Angeles (radiation, procedure, biological, drug)

Active, not recruiting
  • Multiple Myeloma
  • +4 more
  • Total Body Irradiation
  • +5 more
  • Los Angeles, California
    Cedars Sinai Medical Center
Dec 21, 2022

Multiple Myeloma, Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma Trial in Minneapolis (Nicotinamide Expanded Haploidentical

Completed
  • Multiple Myeloma
  • +7 more
  • Nicotinamide Expanded Haploidentical or Mismatched Related Donor Natural Killer Cells
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Nov 2, 2022

Multiple Myeloma, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Charlottesville (Pre-biotic foods/drinks)

Completed
  • Multiple Myeloma
  • +11 more
  • Pre-biotic foods/drinks
  • Charlottesville, Virginia
    University of Virginia
Jan 2, 2023

Immunogenicity of COVID-19 Vaccinations in Autologous HSCT

Not yet recruiting
  • COVID-19
  • +2 more
    • Cologne, NRW, Germany
      University Hospital of Cologne
    Oct 27, 2022

    Biospecimen Procurement for Center for Immuno-Oncology

    Recruiting
    • Multiple Myeloma
    • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Jul 13, 2022

      Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Acute Mixed-Phenotype Leukemia Trial in United States (BMF-219)

      Recruiting
      • Acute Myeloid Leukemia
      • +12 more
      • Los Angeles, California
      • +6 more
      Jun 1, 2022

      Non-hodgkin Lymphoma,B Cell, Multiple Myeloma, Acute Lymphoblastic Leukemia, Adult Trial in Atlanta (Fludarabine,

      Not yet recruiting
      • Non-hodgkin Lymphoma,B Cell
      • +2 more
      • Atlanta, Georgia
        Caitlin Guzowski
      Jun 9, 2023

      Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aplastic Anemia Trial in Columbus (Health Promotion and Education, Medical

      Active, not recruiting
      • Acute Lymphoblastic Leukemia
      • +11 more
      • Health Promotion and Education
      • +3 more
      • Columbus, Ohio
        Ohio State University Comprehensive Cancer Center
      Jul 24, 2023

      Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Leukemia in Remission, Acute Lymphoblastic Leukemia

      Active, not recruiting
      • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
      • +36 more
      • Buffalo, New York
        Roswell Park Cancer Institute
      Jan 23, 2023

      Leukemia, Myeloid, Acute, Leukemia, Lymphoblastic, Acute, L1, Leukemia, Lymphoblastic, Acute, L2 Trial in Melbourne (Venetoclax,

      Recruiting
      • Leukemia, Myeloid, Acute
      • +5 more
      • Melbourne, Victoria, Australia
        Melbourne Health
      Jun 19, 2022

      HIV Infection, Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma, Plasmablastic Lymphoma Trial in United States (procedure, drug,

      Recruiting
      • HIV Infection
      • +10 more
      • Autologous Hematopoietic Stem Cell Transplantation
      • +7 more
      • La Jolla, California
      • +3 more
      Dec 7, 2022

      Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia Trial in Atlanta, Saint Louis, Columbus

      Active, not recruiting
      Has Results
      • Acute Myelogenous Leukemia
      • +10 more
      • Atlanta, Georgia
      • +2 more
      Feb 9, 2022

      Myelodysplastic Syndrome, Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma Trial in Bethesda, Minneapolis (biological, drug,

      Recruiting
      • Myelodysplastic Syndrome
      • +4 more
      • Rituximab
      • +6 more
      • Bethesda, Maryland
      • +1 more
      Aug 20, 2022

      Leukemia, Multiple Myeloma, Myelodysplastic Syndrome Trial in New York (biological, procedure, radiation, drug)

      Active, not recruiting
      • Leukemia
      • +3 more
      • Palifermin
      • +6 more
      • New York, New York
        Memorial Sloan Kettering Cancer Center
      Jan 23, 2023

      T-cell Lymphoma, NK-Cell Lymphoma, T-cell Prolymphocytic Leukemia Trial in United States (Optional Blood Sample, Optional Nail

      Recruiting
      • T-cell Lymphoma
      • +30 more
      • Optional Blood Sample
      • Optional Nail Sample
      • Duarte, California
      • +25 more
      Jul 28, 2023

      Hodgkin's Lymphoma, Lymphoid Leukemia, Lymphoma Trial in Richmond (mycophenolate mofetil, Sargramostim, Filgrastim)

      Active, not recruiting
      • Hodgkin's Lymphoma
      • +17 more
      • mycophenolate mofetil
      • +2 more
      • Richmond, Virginia
        Virginia Commonwealth University/Massey Cancer Center
      Dec 21, 2021

      Myelodysplastic Syndrome, Previously Treated Myelodysplastic Syndrome, Recurrent Adult Acute Myeloid Leukemia Trial in

      Recruiting
      • Myelodysplastic Syndrome
      • +16 more
      • Computed Tomography
      • +6 more
      • Scottsdale, Arizona
      • +2 more
      Feb 3, 2022

      Hodgkin Lymphoma, Lymphoid Leukemia, Multiple Myeloma Trial in Richmond (Intravenous (IV) and oral Vitamin C)

      Active, not recruiting
      • Hodgkin Lymphoma
      • +6 more
      • Intravenous (IV) and oral Vitamin C
      • Richmond, Virginia
        Virginia Commonwealth University/ Massey Cancer Center
      Mar 2, 2022

      Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia Trial in Winston-Salem

      Recruiting
      • Acute Myelogenous Leukemia
      • +9 more
        • Winston-Salem, North Carolina
          Wake Forest Baptist Health
        Nov 23, 2021

        Acute Leukemia, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Minneapolis (HSCT with TBI Regimen, HSCT with

        Recruiting
        • Acute Leukemia
        • +27 more
        • HSCT with TBI Regimen
        • HSCT with Non-TBI Regimen
        • Minneapolis, Minnesota
          Masonic Cancer Center at University of Minnesota
        Apr 12, 2022

        Recurrent Chronic Lymphocytic Leukemia, Recurrent DLBCL, Recurrent Follicular Lymphoma Trial in Seattle (Nivolumab)

        Recruiting
        • Recurrent Chronic Lymphocytic Leukemia
        • +17 more
        • Nivolumab
        • Seattle, Washington
          Fred Hutch/University of Washington Cancer Consortium
        Aug 16, 2022

        Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in

        Active, not recruiting
        • Accelerated Phase Chronic Myelogenous Leukemia
        • +125 more
        • tetanus-CMV fusion peptide vaccine
        • laboratory biomarker analysis
        • Duarte, California
          City of Hope Medical Center
        Feb 28, 2022

        Multiple Myeloma, Non-Hodgkin Lymphoma, Hodgkin Disease Trial in Taiwan (TG-0054 (2.24 mg/kg), TG-0054 (3.14 mg/kg))

        Completed
        Has Results
        • Multiple Myeloma
        • +2 more
        • TG-0054 (2.24 mg/kg)
        • TG-0054 (3.14 mg/kg)
        • Chiayi, Taiwan
        • +5 more
        Apr 14, 2021